Opioid-induced Constipation
📧 Sign up to get email alerts when something new happens for Opioid-induced Constipation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-04-20Clinical Trial Update: Efficacy and Safety of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain [Phase 2, Phase 3]
Clinical trial update on tegaserod for opioid-induced constipation in adults with non-cancer pain; the Phase 2/3 study was terminated.
-
CLINICAL_TRIALS trial_result · 2011-08-23Clinical Trial Update: ALK37-003: A Study of RDC-1036 (ALKS 37) in Adults With Opioid-induced Constipation (OIC) [Phase 2]
A Phase 2 trial of RDC-1036 (ALKS 37) in adults with opioid-induced constipation has completed.
-
FDA approval · 2010-09-27FDA Approved: RELISTOR — Supplemental Application (Salix Pharmaceuticals, Inc.)
The FDA approved a supplemental application for RELISTOR (METHYLNALTREXONE BROMIDE) submitted by Salix Pharmaceuticals, Inc. The changes rel…
-
FDA approval · 2010-07-23FDA Approved: RELISTOR — Supplemental Application (Salix Pharmaceuticals, Inc.)
FDA approved a supplemental application for Relistor (methylnaltrexone bromide) submitted by Salix Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2010-05-11Clinical Trial Update: Study Evaluating Subcutaneous MOA-728 for the Treatment of Opioid-Induced Constipation (OIC) in Subjects With Chronic Non-Malignant Pain [Phase 3]
Phase 3 trial update for subcutaneous MOA-728 in opioid-induced constipation associated with chronic non-malignant pain; study completed wit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-01-15Clinical Trial Update: Methylnaltrexone for Treatment of Opiate-Induced Constipation in the Intensive Care Unit [Phase 3]
The update covers a Phase 3 clinical trial evaluating methylnaltrexone for treating opioid-induced constipation in ICU patients. Sponsor: St…
-
FDA approval · 2009-11-04FDA Approved: RELISTOR — Supplemental Application (Salix Pharmaceuticals, Inc.)
FDA approved a supplemental application for RELISTOR (methylnaltrexone bromide) from Salix Pharmaceuticals. The approval updates the labelin…
-
FDA approval · 2008-04-24FDA Approved: RELISTOR — Original Application (Salix Pharmaceuticals, Inc.)
FDA approved RELISTOR (methylnaltrexone bromide) through its original application for the treatment of opioid-induced constipation in patien…